What Does it Cover?
In this technical presentation, we will discuss the use of polymeric microspheres in diagnostic assays. We will provide you with a survey of the materials used in this field, examples of readers available for this growing market, case studies, and a first preview of novel products to be released in 2020. Material considerations to be discussed include key attributes needed to select the best spheres for qualitative and quantitative assays (such as size, functional group, and color). We will also share best practices to troubleshoot protein binding in qualitative assay development using our raw materials. This information will be of interest to individuals involved in developing and validating qualitative and quantitative assays.
What Will You Learn?
Diagnostic Test Manufacturers
Hugues (Augier) de Crémiers
Application Specialist, Diagnostic Solutions, Estapor®
Hugues joined MilliporeSigma Chimie Fr as Sales Manager Northern Europe in 2008 for the Estapor® Microsphere franchise. As an Application Specialist he works with Account Managers to develop product application solutions in support of numerous IVD partners in their use of Estapor® beads as raw materials.
Prior to joining MilliporeSigma Hugues was International Business Manager for 3 years at a French IVD company, growing the distribution channels in the IVD field. His focus areas included infectious diseases and autoimmunity. Prior to that Hugues was inside Sales Engineer at Oxford Instruments (UK) in the field of Superconducting magnets for 3 years.
Hugues’ years of IVD development experience is supported by his strong chemistry background, having achieved a Bachelor of Science from Newcastle (UK) and a Ph.D. from Edinburgh (UK). He has published several papers in peer reviewed journals and presented at various international conferences.
Research. Development. Production.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.